mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-06 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.0002 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.002 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.005 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.006 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.006 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.008 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |